
Filippo Pietrantonio
Filippo Pietrantonio is a leading oncologist specializing in gastrointestinal oncology at the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy. He is recognized for his research on stomach cancer, particularly in the context of early diagnosis and the treatment of advanced forms of the disease. His studies have contributed significantly to understanding the importance of recognizing early symptoms and the efficacy of new therapeutic approaches, such as immunotherapy combined with chemotherapy.
Not in the pool (under ¢1).
Recent news mentions
Filippo Pietrantonio is associated with the Istituto Nazionale Tumori di Milano, which participated in the study RASolute 302.
Tumore del pancreas, un nuovo farmaco rivoluziona le cureFilippo Pietrantonio is the head of the Gastrointestinal Oncology Unit at the National Cancer Institute in Milan.
Tumore al colon, l'esercizio fisico può essere come un farmaco (o persino meglio)?Filippo Pietrantonio is the head of the Gastrointestinal Oncology Unit at the National Cancer Institute in Milan.
Tumore allo stomaco, ancora troppe le diagnosi tardive: i sintomi da non trascurare


